Cutting edge: Two distinct motifs within the Fas ligand tail regulate Fas ligand-mediated costimulation

Journal of Immunology

Volumn 179, Issue 9, 2007, Pages 5639-5643

  Sun, Mingyi ^a   Lee, Shinhee ^a   Karray, Saoussen ^b,c   Levi Strauss, Matthieu ^b,d   Ames, Kristina T ^a   Fink, Pamela J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CASEIN KINASE I; FAS LIGAND; PROLINE; TRANSCRIPTION FACTOR NFAT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOMODULATION; LIPID RAFT; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; TRANSCRIPTION INITIATION; ANIMAL; CELL CULTURE; CHEMISTRY; ENZYME ACTIVATION; GENE DELETION; GENETICS; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; ANIMALS; BINDING SITES; CASEIN KINASE I; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; FAS LIGAND PROTEIN; GENE DELETION; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NFATC TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 38449113090     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.9.5639     Document Type: Article

References (23)

1. Frauwirth, K. A., and C. B. Thompson. 2002. Activation and inhibition of lymphocytes by costimulation. J. Clin. Invest. 109: 296-299.
2. Croft, M. 2003. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev. 14: 265-273.
3. Sun, M., and P. J. Fink. 2007. A new class of reverse signaling costimulators belongs to the TNF family. J. Immunol. 179: 4307-4312.
4. Rudd, C. E., and H. Schneider. 2003. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 3: 544-556.
5. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3: 609-620.
6. Sun, M., K. T. Ames, I. Suzuki, and P. J. Fink. 2006. The cytoplasmic domain of Fas ligand costimulates TCR signals. J. Immunol. 177: 1481-1491.
7. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187: 123-128.
8. + T cells. Proc. Natl. Acad. Sci. USA 97: 1707-1712.
9. + T cells. J. Immunol. 165: 5537-5543.
10. Boursalian, T. E., and P. J. Fink. 2003. Mutation in Fas ligand impairs maturation of thymocytes bearing moderate affinity T cell receptors. J. Exp. Med. 198: 349-360.
11. Hane, M., B. Lowin, M. Peitsch, K. Becker, and J. Tschopp. 1995. Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain. FEBS Lett. 373: 265-268.
12. Ghadimi, M. P., R. Sanzenbacher, B. Thiede, J. Wenzel, Q. Jing, M. Plomann, A. Borkhardt, D. Kabelitz, and O. Janssen. 2002. Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178). FEBS Lett. 519: 50-58.
13. Karray, S., C. Kress, S. Cuvellier, C. Hue-Beauvais, D. Damotte, C. Babinet, and M. Levi-Strauss. 2004. Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele. J. Immunol. 172: 2118-2125.
14. Blott, E. J., G. Bossi, R. Clark, M. Zvelebil, and G. M. Griffiths. 2001. Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J. Cell Sci. 114: 2405-2416.
15. Jodo, S., V. J. Pidiyar, S. Xiao, A. Furusaki, R. Sharma, T. Koike, and S. T. Ju. 2005. Fas ligand (CD178) cytoplasmic tail is a positive regulator of Fas ligand-mediated cytotoxicity. J. Immunol. 174: 4470-4474.
16. Nachbur, U., D. Kassahn, S. Yousefi, D. F. Legler, and T. Brunner. 2006. Posttranscriptional regulation of Fas (CD95) ligand killing activity by lipid rafts. Blood 107: 2790-2796.
17. Cahuzac, N., W. Baum, V. Kirkin, F. Conchonaud, L. Wawrezinieck, D. Marguet, O. Janssen, M. Zornig, and A. O. Hueber. 2006. Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity. Blood 107: 2384-2391.
18. + thymocytes by the anti-fas antibody. J. Exp. Med. 181: 485-491.
19. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol Today 16: 39-43.
20. Kane, L. P., and A. Weiss. 2003. The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol. Rev. 192: 7-20.
21. + T lymphocytes. J. Immunol. 160: 3642-3647.
22. Janssen, O., J. Qian, A. Linkermann, and D. Kabelitz. 2003. CD95 ligand- death factor and costimulatory molecule? Cell Death Differ. 10: 1215-1225.
23. Eissner, G., W. Kolch, and P. Scheurich. 2004. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev. 15: 353-366.